Prognostic and predictive impact of cytogenetic changes in relapsed multiple myeloma patients treated with bortezomib or thalidomid based regiments: a Czech group experience

Warning

This publication doesn't include Faculty of Education. It includes Faculty of Medicine. Official publication website can be found on muni.cz.

Authors	SMETANA Jan KUGLÍK Petr GREŠLIKOVÁ Henrieta KUPSKÁ Renata NĚMEC Pavel BERÁNKOVÁ Kristina ZAORALOVÁ Romana FILKOVÁ Hana POUR Luděk KREJČÍ Marta ZAHRADOVÁ Lenka HOLÁNEK Michal ADAM Zdeněk HÁJEK Roman
Year of publication	2010
Type	Conference abstract
MU Faculty or unit	Faculty of Medicine
Citation
Related projects:	Molecular basis of cell and tissue regulations University Research Centre - Czech Myeloma Group From classic prognostic markers to clinical applications in selected pharmacogenomic and pharmacoproteomic projects in multiple myeloma and monoclonal gammapathies Úloha abnormalit chromozómu 1 a kaskády NF-kappaβ v patogenezi mnohočetného myelomu